Contributions of molecular genetics to the clinical management of colorectal cancer

American Journal of Surgery

Volumn 171, Issue 1, 1996, Pages 10-15

  Stern, Hartley S ^a,b  

^a UNIVERSITY OF OTTAWA   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOMATOUS POLYP; BASE MISPAIRING; CANCER REGISTRY; COLORECTAL CANCER; CONFERENCE PAPER; FECES CULTURE; GENE MUTATION; MOLECULAR GENETICS; ONCOGENE K RAS; PRIORITY JOURNAL; RISK ASSESSMENT;

EID: 0030040257     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9610(99)80065-8     Document Type: Conference Paper

References (45)

1. Hoffman KJ, Taurbor ES, Chase GA, et al. Physicians' knowledge of genetics and genetic tests. Acad Med. 1993;68:625-631.
2. Vogelstein B, Fearon EE, Hamilton SR, et al. Genetic alterations during colorectal-tumour development. NEJM. 1988;319:525-532.
3. Bishop DT, Thomas HJW. The genetics of colorectal cancer. Cancer Surveys. 1990;9:584-604.
4. Nowell PC. Mechanisms of tumour progression. Cancer Res. 1986;46:2203-2207.
5. Modrich P. Mechanisms and biological effects of mismatch repair. Ann Rev Genet. 1991;25:229-253.
6. Bussey HJR. Familial polyposis coli. In: Family Studies, Histopathology, Differential Diagnosis and Results of Treatment. Baltimore, Md.: Johns Hopkins University Press; 1975.
7. Stern HS, Smith A. Recognition, screening and medical management of familial adenomatous polyposis. Sem Colon Rect Surg. 1995;6:19-24.
8. Berk T, Cohen Z, McLeod R, et al. Management of mesenteric desmoid tumours in familial adenomatous polyposis. Can J Surg. 1992;35:393-395.
9. Jagelman DG. Extracolonic manifestations of familial polyposis coli. Cancer Genet Cytogenet. 1987;27:319-325.
10. Berk T, Stem H. Screening, management and surveillance for families with familial adenomatous polyposis. Gostroenterol Endosc Clin NA. 1993;3:725-736.
11. Nugent KP, Phillips RKS. Rectal cancer risk in patients treated for familial adenomatous polyposis and an ileorectal anastomosis. A cause for concern. Br J Surg. 1992;79:1204-1206.
12. Decosse JJ, Bulow S, Neale K, et al. Rectal cancer risk in patients treated for familial adenomatous polyposis. Br J Surg. 1992;79: 1372-1374.
13. Vasen HPA, Griffioen G, Offerhaus GJA, et al. The value of screening and central registration of families with familial adenomatous polyposis. A study of 82 families in the Netherlands. Dis Colon Rectum. 1990;33:227-230.
14. Cohen Z, Berk T, McLeod RS. A clinician's approach to patients with familial adenomatous polyposis and their first degree relatives. In: Herrera L, ed. Familial Adenomatous Polyposis. New York, NY: Alan R. Liss; 1990:91-96.
15. Bodmer WF, Bailey CJ, Bodmer J, et al. Localization of the gene for familial polyposis coli on chromosome 5. Nature. 1987;328: 614-616.
16. Kinzler KW, Nilbert MC, Su L-K, et al. Identification of FAP locus genes from chromosome 5q21. Science. 1991;253:661-665.
17. Groden J, Thliverus A, Sarmowitz W, et al. Identification and characterization of the familial adenomatous polyposis coli gene. Cell. 1991;66:589-600.
18. Fearon ER, Vogelstein B. A genetic model for colorectal tumori-genesis. Cell. 1990;61:759-767.
19. Rubinfield B, Souza B, Albert I, et al. Association of the APC gene product with B catenin. Science. 1993;262:1731-1734.
20. Powell SM, Petersen GM, Krush AJ, et al. Molecular diagnosis of familial adenomatous polyposis. NEJM. 1993;329:1982-1987.
21. Spirio L, Olschwang S, Groden J, et al. Alleles of the APC gene: an attenuated form of familial polyposis. Cell. 1993;75:951-957.
22. Bapat BV, Odze R, Mitri A, et al. Identification of somatic APC gene mutations in periampullary adenomas in a patient with familial adenomatous polyposis (FAP). Hum Mol Genet. 1993;11:1957-1959.
23. Warthin AS. Heredity with reference to carcinoma. Arch Intern Med. 1913;12:546-555.
24. Lynch HT, Swyrk TC, Watson P, et al. Genetics, natural history, tumour spectrum and pathology of hereditary non-polyposis colorectal cancer: an updated review. Gostroenterology.1993;104:1535-1549.
25. Vasen HFA, Offerhaus GJA, den Hartog Jager FCA, et al. The tumour spectrum in hereditary non-polyposis colorectal cancer: a study of 24 kindreds in the Netherlands. Int J Cancer. 1990;46:31-34.
26. Fishel R, Lescoe MK, Rao MSR, et al. The human mutation glue homolog MSH2 and its association with hereditary non-polyposis colon cancer. Cell. 1993;75:1027-1038.
27. Papadopoulous N, Nicolides NC, Wei YF, et al. Mutation of a MUTL homolog in hereditary colon cancer. Science. 1994;263: 1625-1629.
28. Nicolaides NCN, Papadopoulos B, Lui B, et al. Mutations of two PMS homologs in hereditary non-polyposis colon cancer. Nature. 1994;253:665-669.
29. Wagner JL, Herdman RC, Wadhwa S. Cost effectiveness of colorectal cancer screening in the elderly. Ann Intern Med. 1991;115: 807-817.
30. Sidransky D, Tokino T, Hamilton SR, et al. Identification of ras oncogene mutations in the stool of patients with curable colorectal tumours. Science. 1992;256:102-105.
31. Tobi M, Luo FC, Ronai Z. Detection of K-ras mutation in colonic effluent samples from patients without evidence of colorectal carcinoma. J Natl Canc Inst. 1994;86:1007-1010.
32. Kern SE, Fearon ER, Kasper BA, et al. Allelic loss in colorectal carcinoma. JAMA. 1989;261:3099-3103.
33. Laurent-Puig P, Olschwang S, Delattre O, et al. Survival and acquired genetic alterations in colorectal cancer. Gastroenterology. 1992; 102:1136-1141.
34. Johan G, Offerhaus A, De Feyter EP, et al. The relationship of DNA aneuploidy to molecular genetic alterations in colorectal carcinoma. Gastroenterology. 1992;102:1612-1619.
35. Jen J, Hoguen K, Piantudosi S, et al. Allelic loss of chromosome 18q and prognosis in colorectal cancer. NEJM. 1994;331:213-221.
36. Lino H, Fukayama M, Maeda Y, et al. Molecular genetics for clinical management of colorectal carcinoma: 17p, 18q and 22q loss of heterozygosity and decreased DCC expression are correlated with the metastatic potential. Cancer. 1994;73:1324-1331.
37. Campo EL, Miquel R, Jares P, et al. Prognostic significance of the loss of heterozygosity of Nm23-H1 and p53 genes in human colorectal carcinomas. Cancer. 1994;73:2913-2921.
38. Khine K, Smith D, Hak-Su-G. High frequency of allelic deletion on chromosome 17p in advanced colorectal cancer. Cancer. 1994;73: 28-35.
39. Scott N, Sagar J, Stewart GE, et al. p53 in colorectal cancer: clinicopathological correlation and prognostic significance. Br J Cancer. 1991;63:317-339.
40. Remvikos Y, Tominaga O, Hammel P, et al. Increased p53 protein content of colorectal tumours correlates with poor survival. Br J Cancer. 1992;66:758-764.
41. Starzynska T, Bromley M, Ghosh A, et al. Prognostic significance of p53 overexpression in gastric and colorectal carcinoma. Br J Cancer. 1992;66:558-562.
42. Sun X-F, Carstensen JM, Zhang H, et al. Prognostic significance of cytoplasmic p53 oncoprotein in colorectal adenocarcinoma. Lancet. 1992;340:1369-1373.
43. Bell SM, Scott N, Cross D, et al. Prognostic value of p53 overexpression and c-Ki-ras gene mutations in colorectal cancer. Gastroenterology. 1993;104:57-64.
44. Nathanson SD, Linden MD, Tender P, et al. Relationship among p53, stage and prognosis of large bowel cancer. Dis Colon Rectum. 1994;37:527-534.
45. Hamelin R, Laurent-Puis P, Olschwang S, et al. Association of p53 mutations with short survival in colorectal cancer. Gastroenterology. 1994;106:48-52.